Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-10.59%
↑ 76% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-43.93%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -10.59% |
| 2023 | -45.91% |
| 2022 | -68.03% |
| 2021 | -22.12% |
| 2020 | -53.72% |
| 2019 | -107.14% |
| 2018 | 0.00% |